Immunohematology Market Size, Share, and Trends 2024 to 2034

The global immunohematology market size is calculated at USD 2.86 billion in 2025 and is forecasted to reach around USD 4.06 billion by 2034, accelerating at a CAGR of 3.97% from 2025 to 2034. The North America immunohematology market size surpassed USD 1.07 billion in 2024 and is expanding at a CAGR of 4.02%% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 4342
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunohematology Market 

5.1. COVID-19 Landscape: Immunohematology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunohematology Market, By Product

8.1. Immunohematology Market, by Product

8.1.1 Analyzers

8.1.1.1. Market Revenue and Forecast

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Immunohematology Market, By Technology

9.1. Immunohematology Market, by Technology

9.1.1. Biochips

9.1.1.1. Market Revenue and Forecast

9.1.2. Gel Cards

9.1.2.1. Market Revenue and Forecast

9.1.3. Microplates

9.1.3.1. Market Revenue and Forecast

9.1.4. PCR

9.1.4.1. Market Revenue and Forecast

9.1.5. Erythrocyte-Magnetized Technology

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Immunohematology Market, By End-User 

10.1. Immunohematology Market, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast

10.1.2. Diagnostic Laboratories

10.1.2.1. Market Revenue and Forecast

10.1.3. Blood banks

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Immunohematology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product

11.1.2. Market Revenue and Forecast, by Technology

11.1.3. Market Revenue and Forecast, by End-User

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product

11.1.4.2. Market Revenue and Forecast, by Technology

11.1.4.3. Market Revenue and Forecast, by End-User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product

11.1.5.2. Market Revenue and Forecast, by Technology

11.1.5.3. Market Revenue and Forecast, by End-User

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product

11.2.2. Market Revenue and Forecast, by Technology

11.2.3. Market Revenue and Forecast, by End-User

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product

11.2.4.2. Market Revenue and Forecast, by Technology

11.2.4.3. Market Revenue and Forecast, by End-User

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product

11.2.5.2. Market Revenue and Forecast, by Technology

11.2.5.3. Market Revenue and Forecast, by End-User

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product

11.2.6.2. Market Revenue and Forecast, by Technology

11.2.6.3. Market Revenue and Forecast, by End-User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product

11.2.7.2. Market Revenue and Forecast, by Technology

11.2.7.3. Market Revenue and Forecast, by End-User

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product

11.3.2. Market Revenue and Forecast, by Technology

11.3.3. Market Revenue and Forecast, by End-User

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product

11.3.4.2. Market Revenue and Forecast, by Technology

11.3.4.3. Market Revenue and Forecast, by End-User

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product

11.3.5.2. Market Revenue and Forecast, by Technology

11.3.5.3. Market Revenue and Forecast, by End-User

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product

11.3.6.2. Market Revenue and Forecast, by Technology

11.3.6.3. Market Revenue and Forecast, by End-User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product

11.3.7.2. Market Revenue and Forecast, by Technology

11.3.7.3. Market Revenue and Forecast, by End-User

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product

11.4.2. Market Revenue and Forecast, by Technology

11.4.3. Market Revenue and Forecast, by End-User

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product

11.4.4.2. Market Revenue and Forecast, by Technology

11.4.4.3. Market Revenue and Forecast, by End-User

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product

11.4.5.2. Market Revenue and Forecast, by Technology

11.4.5.3. Market Revenue and Forecast, by End-User

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product

11.4.6.2. Market Revenue and Forecast, by Technology

11.4.6.3. Market Revenue and Forecast, by End-User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product

11.4.7.2. Market Revenue and Forecast, by Technology

11.4.7.3. Market Revenue and Forecast, by End-User

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product

11.5.2. Market Revenue and Forecast, by Technology

11.5.3. Market Revenue and Forecast, by End-User

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product

11.5.4.2. Market Revenue and Forecast, by Technology

11.5.4.3. Market Revenue and Forecast, by End-User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product

11.5.5.2. Market Revenue and Forecast, by Technology

11.5.5.3. Market Revenue and Forecast, by End-User

Chapter 12. Company Profiles

12.1. Grifols S.A.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Immucor Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Thermo Fisher Scientific

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Merck KGaA

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global immunohematology market size is expected to increase USD 4.06 billion by 2034 from USD 2.75 billion in 2024.

The global immunohematology market will register growth rate of 3.97% between 2025 and 2034.

The major players operating in the immunohematology market are Grifols S.A., Immucor Inc., Thermo Fisher Scientific, Merck KGaA, Abbott Laboratories, and Others.

The driving factors of the immunohematology market are the meeting clinical demand through enhanced safety and efficiency and Advancements in transfusion medicine and quality assurance.

North America region will lead the global immunohematology market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client